Alumis is  a precision medicines company looking to eliminate the “all comer” approach that is seen with today’s treatments for people with autoimmune disease. They are leveraging a precision analytics platform, powered by Foresite Labs, coupled with a team of experts with deep experience in precision medicine drug development and immunology, in order to create medicines that change the lives of people with autoimmune disease.

Biotechnology

Education

Alumis

Alumis' headquarters in Albuquerque, NM, United States

Martin Babler

John Schroer

Karen Pellett

Lance Shinseki

David Goldstein

Jörn Drappa

Jack Danilkowicz

Mark Kresnak

Sara Klein

Lily Gong

Mark Bradley

Alan Colowick

Zhengbin Yao

Julian Baker

Jim Tananbaum

Sapna Srivastava

The Clinical Development and Research team at Alumis is dedicated to advancing precision medicine for autoimmune diseases by designing and overseeing innovative clinical trials. Comprising experts in genetics, immunology, toxicology, and biostatistics, the team collaborates to ensure that drug development is guided by robust data and regulatory compliance, ultimately aiming to deliver tailored therapies that significantly improve patient outcomes.

Clinical Development and Research

The Leadership Team at Alumis is responsible for steering the strategic direction and operational execution of the company’s initiatives in precision medicine for autoimmune diseases. Comprising experts in scientific development, biometrics, legal, and organizational culture, the team collaborates to ensure that Alumis effectively leverages its analytics platform and expertise to develop targeted therapies that significantly improve patient outcomes. Their collective leadership fosters innovation, drives regulatory compliance, and nurtures a culture that attracts and retains top talent in the field.

Leadership Team

The Clinical Development Team at Alumis is responsible for designing and overseeing the clinical trials of innovative precision medicines targeting autoimmune diseases. This team collaborates closely with cross-functional experts to ensure that clinical programs are scientifically sound, compliant with regulatory standards, and aligned with the company’s strategic goals. Their mission is to generate robust clinical evidence that demonstrates the safety and efficacy of new therapies, ultimately translating scientific advancements into transformative treatment options for patients.

Clinical Development Team

The Development and Information Systems team at Alumis is responsible for integrating advanced technology and data analytics to streamline the drug development process. They manage the precision analytics platform, ensuring it supports the research and operational needs of the company, while also overseeing program and portfolio management to optimize resources and project timelines. This team plays a critical role in enhancing collaboration between scientific and business functions, ultimately driving innovation in autoimmune disease therapies.

Development and Information Systems

The Medical and Regulatory Affairs team at Alumis is responsible for ensuring that the company’s precision medicine initiatives comply with regulatory standards while facilitating the clinical development process. This team provides strategic oversight on clinical trials, collaborates on biostatistical analyses, and works closely with regulatory agencies to secure approvals for innovative therapies targeting autoimmune diseases. Their expertise helps to navigate complex medical regulations, ensuring that all efforts align with the ultimate goal of delivering impactful treatments to patients.

Alumis

Org chart

Board & advisors

Teams

Clinical Development and Research

Leadership Team

Clinical Development Team

Development and Information Systems

Medical and Regulatory Affairs

Offices

Alumis

Org chart

Board & advisors

Teams

Clinical Development and Research

Leadership Team

Clinical Development Team

Development and Information Systems

Medical and Regulatory Affairs

Offices

Related companies